NIH-funded research R01 grant

Developing a new method for delivering gene therapy using mouse models

Official title: Prototype Mouse Models for SEND-Based mRNA Delivery and Technology Development

Funded at University of Nebraska Medical Center · NIH-10804267 · Data updated 2026-11-12

This study is looking at a new way to deliver gene therapy using special particles that can carry healthy genes to the right cells, which could lead to better treatments for genetic diseases.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startSeptember 18, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$330,025
NIH project number1R01GM149756-01A1
Project IDNIH-10804267 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic diseases that could be treated through gene therapy.

Less likely to help

Patients with conditions not related to genetic disorders may not receive any benefit from this research.

What this research studies

This research investigates a novel approach to gene therapy delivery using a system called SEND, which utilizes a cellular protein to create viral-like particles that can transport healthy gene copies to target cells. By studying this process in mouse models, the researchers aim to overcome the limitations of current gene therapy delivery methods, such as viral vectors and lipid nanoparticles. The project will explore how these SEND particles can effectively deliver genetic material, potentially leading to more reliable treatments for genetic diseases. Patients may benefit from advancements in gene therapy that could arise from this innovative delivery technology.

Why it matters

Potential benefit: If successful, this research could lead to more effective gene therapies for patients with genetic disorders.

How similar studies have gone: While the SEND system shows promise based on preliminary results, it represents a novel approach that has not yet been widely tested in clinical settings.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Gurumurthy, Channabasavaiah — University of Nebraska Medical Center
  • Study coordinator: Gurumurthy, Channabasavaiah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.